New study tests virtual coaching to help young cancer survivors navigate insurance maze

NCT ID NCT05829070

Recruiting now Knowledge-focused Sponsor: University of Utah Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a 4-session virtual program called CHAT-S for young adult cancer survivors aged 26-39. The program aims to improve their understanding of health insurance, reduce financial burden, and help them get recommended follow-up cancer screenings. Researchers will track 300 participants from two healthcare systems to see if the program works.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: CHAT-S behavioral intervention (virtual sessions with a patient navigator)
What this could lead to: If successful, this program could help young cancer survivors better manage their health insurance and reduce financial stress, potentially improving their long-term health follow-up.
What could go wrong: This is a relatively small, early-stage trial focused on education, not a medical treatment. Results may not apply to all cancer types or healthcare systems, and the program may not lead to lasting changes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer cancer colorectal cancer lymphoma neoplasm sarcoma testicular cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CANCER

Contacts and locations

Locations

Intermountain Health
RECRUITING

Murray, Utah, 84107, United States
University of Utah
RECRUITING

Salt Lake City, Utah, 84112, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.